Phase II trials are used to establish an initial measure of effectiveness and to explore safety in a small number of patients with the disease targeted by the NCE.
Vipimo vya awamu ya II hutumika kuanzisha usomaji wa kwanza wa ufanisi na kuchunguza zaidi usalama katika idadi ndogo ya watu wenye ugonjwa wanaolengwa na NCE.